128 related articles for article (PubMed ID: 462918)
1. Improved yields of factor VIII from heparinized plasma.
Rock GA; Cruickshank WH; Tackaberry ES; Palmer DS
Vox Sang; 1979; 36(5):294-300. PubMed ID: 462918
[TBL] [Abstract][Full Text] [Related]
2. Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.
Vermeer C; Soute BA; Ates G; Brummelhuis HG
Vox Sang; 1976; 30(1):1-22. PubMed ID: 1251567
[TBL] [Abstract][Full Text] [Related]
3. Characterization of factors affecting the stability of frozen heparinized plasma.
Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
[TBL] [Abstract][Full Text] [Related]
4. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
[TBL] [Abstract][Full Text] [Related]
5. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
Wensley RT; Snape TJ
Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
[TBL] [Abstract][Full Text] [Related]
6. Influence of the primary anticoagulant on the recovery of factor VIII in cryoprecipitate.
de Wit HJ; Scheer G; Muradin J; van der Does JA
Vox Sang; 1986; 51(3):172-5. PubMed ID: 3101286
[TBL] [Abstract][Full Text] [Related]
7. Accumulative effect of DDAVP and heparin in increasing plasma factor VIII levels.
Rock G; Palmer DS
Vox Sang; 1981; 41(1):56-60. PubMed ID: 6798759
[TBL] [Abstract][Full Text] [Related]
8. Contributions to the optimal use of human blood. VIII. Stability of blood coagulation factor VII during collection and storage of whole blood and plasma.
Vermeer C; Soute BA; Ates G; Hellings JA; Brummelhuis HG
Vox Sang; 1976; 31(1 SUPPL):55-67. PubMed ID: 12616
[TBL] [Abstract][Full Text] [Related]
9. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
[TBL] [Abstract][Full Text] [Related]
10. Preparation of cryoprecipitated factor VIII concentrates.
Slichter SJ; Counts RB; Henderson R; Harker LA
Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
[TBL] [Abstract][Full Text] [Related]
11. Influence of heparin and calcium chloride on assay, stability, and recovery of factor VIII.
Morgenthaler JJ; Zuber T; Friedli H
Vox Sang; 1985; 48(1):8-17. PubMed ID: 3918394
[TBL] [Abstract][Full Text] [Related]
12. The stability of factor VIII in heparinized plasma.
Krachmalnicoff A; Thomas DP
Thromb Haemost; 1983 Jun; 49(3):224-7. PubMed ID: 6410534
[TBL] [Abstract][Full Text] [Related]
13. Human factor VIII: a calcium-linked protein complex.
Mikaelsson ME; Forsman N; Oswaldsson UM
Blood; 1983 Nov; 62(5):1006-15. PubMed ID: 6414552
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
Tran TH; Duckert F
Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
[TBL] [Abstract][Full Text] [Related]
15. Effect of citrate anticoagulants on factor VIII levels in plasma.
Rock G; Tittley P; Fuller V
Transfusion; 1988; 28(3):248-52. PubMed ID: 3130694
[TBL] [Abstract][Full Text] [Related]
16. Stability of VIII:C in plasma: the dependence on protease activity and calcium.
Rock GA; Cruickshank WH; Tackaberry ES; Ganz PR; Palmer DS
Thromb Res; 1983 Mar; 29(5):521-35. PubMed ID: 6407138
[TBL] [Abstract][Full Text] [Related]
17. Severely heated therapeutic factor VIII concentrate of high specific activity.
Winkelman L; Owen NE; Evans DR; Evans H; Haddon ME; Smith JK; Prince PJ; Williams JD; Lane RS
Vox Sang; 1989; 57(2):97-103. PubMed ID: 2506696
[TBL] [Abstract][Full Text] [Related]
18. Studies on the procurement of coagulation factor VIII: selective precipitation of factor VIII with hydrophilic polymers.
Farrugia A; Griffin B; Pepper D; Prowse C
Thromb Haemost; 1984 Jul; 51(3):338-42. PubMed ID: 6437004
[TBL] [Abstract][Full Text] [Related]
19. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
Mason EC; Pepper DS; Griffin B
Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
[TBL] [Abstract][Full Text] [Related]
20. A comparison of factor VIII activity in cryoprecipitates prepared from ACD and CPD plasma.
Shanberge JN; Gruhl MC; Ikemori R; Inoshita K; Chalos MK; Aster RH
Transfusion; 1972; 12(4):251-8. PubMed ID: 5039460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
